https:// doi. org/ 10. 1186/ s12885- 020- 07169-6 4. Das S, Ciombor KK, Haraldsdottir S, Goldberg RM (2018) Prom- ising new agents for colorectal cancer. Curr Treat Options Oncol 19:29. https:// doi. org/ 10. 1007/ s11864- 018- 0543-z 5. Kubo T, Shinkawa T, Kikuchi Y et al (2021) Fundamental and essential knowledge for pathologists engaged in the research and practice of immune checkpoint inhibitor-based cancer immuno- therapy. Front Oncol 11:679095. https:// doi. org/ 10. 3389/ fonc. 2021.